Market Research Logo

Global Alzheimer's Disease Drug Market Research Report 2017

Global Alzheimer's Disease Drug Market Research Report 2017

This report studies the Alzheimer¡¯s Disease Drug market status and outlook of global and major regions, from angles of players, regions, product types and end industries; this report analyzes the top players in global and major regions, and splits the Alzheimer¡¯s Disease Drug market by product type and applications/end industries.

In the last several years, global market of alzheimer¡¯s disease drug change huge. In 2016, global revenue of alzheimer¡¯s disease drug is nearly 3161.3 M USD. And the global growth rate is at -10.95% from 2012 to 2016


The major players in global Alzheimer¡¯s Disease Drug market include
Allergan
Eisai
Novartis
Daiichi Sankyo
Merz Pharma
Pfizer
Johnson & Johnson
Lundbeck.

Geographically, this report is segmented into several key Regions, with Sales, Sales, revenue, Market Share (%) and Growth Rate (%) of Alzheimer¡¯s Disease Drug in these regions, from 2012 to 2022 (forecast), covering
North America
Europe
China
Japan
Row


On the basis of product, the Alzheimer¡¯s Disease Drug market is primarily split into
Donepezil
Memantine
Rivastigmine


On the basis on the end users/applications, this report covers
Early to Moderate Stages
Moderate to Severe Stages


1 Alzheimer¡¯s Disease Drug Market Overview
1.1 Alzheimer¡¯s Disease Drug Product Overview
1.2 Alzheimer¡¯s Disease Drug Segment by Types (Brand)
1.2.1 Alzheimer¡¯s Disease Drug Segment by Types
1.2.2 Global Alzheimer¡¯s Disease Drug Sales Market Share (%) by Types in 2016
1.2.3 Donepezil
1.2.4 Memantine
1.2.5 Rivastigmine
1.3 Global Alzheimer¡¯s Disease Drug Segment by Applications
1.4 Global Alzheimer¡¯s Disease Drug Market by Regions (2012-2022)
1.4.1 North America Alzheimer¡¯s Disease Drug Status and Prospect (2012-2022)
1.4.2 China Alzheimer¡¯s Disease Drug Status and Prospect (2012-2022)
1.4.3 Europe Alzheimer¡¯s Disease Drug Status and Prospect (2012-2022)
1.4.4 Japan Alzheimer¡¯s Disease Drug Status and Prospect (2012-2022)
1.5 Global Alzheimer¡¯s Disease Drug Market Size (2012-2022)
1.5.1 Global Alzheimer¡¯s Disease Drug Revenue (M USD) Status and Outlook (2012-2022)
1.5.2 Global Alzheimer¡¯s Disease Drug Sales (M Units) Status and Outlook (2012-2022)
2 Global Alzheimer¡¯s Disease Drug Market Competition by Manufacturers/Brand
2.1 Global Alzheimer¡¯s Disease Drug Sales (M Units) and Share by Manufacturers (2012-2017)
2.2 Global Alzheimer¡¯s Disease Drug Revenue (M USD) and Share by Manufacturers (2012-2017)
2.3 Global Alzheimer¡¯s Disease Drug Average Price (USD/Unit) by Manufacturers (2012-2017)
2.4 Manufacturers Alzheimer¡¯s Disease Drug Headquarters, Found Date, Product Types
2.5 Alzheimer¡¯s Disease Drug Market Competitive Situation and Trends
2.5.1 Alzheimer¡¯s Disease Drug Market Concentration Rate
2.5.2 Alzheimer¡¯s Disease Drug Market Share (%) of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion
3 Global Alzheimer¡¯s Disease Drug Sales (M Units), Revenue (M USD) by Regions (2012-2017)
3.2 Global Alzheimer¡¯s Disease Drug Sales (M Units) and Market Share (%) by Regions (2012-2017)
3.3 Global Alzheimer¡¯s Disease Drug Revenue (M USD) and Market Share (%) by Regions (2012-2017)
3.3 Global Alzheimer¡¯s Disease Drug Sales (M Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
3.5 North America Alzheimer¡¯s Disease Drug Sales (M Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
3.6 Europe Alzheimer¡¯s Disease Drug Sales (M Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
3.7 China Alzheimer¡¯s Disease Drug Sales (M Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
3.8 Japan Alzheimer¡¯s Disease Drug Sales (M Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2012-2017)
4 Global Alzheimer¡¯s Disease Drug Sales, Revenue, Price Trend by Types
4.1 Global Alzheimer¡¯s Disease Drug Sales (M Units) and Market Share (%) by Types (2012-2017)
4.2 Global Alzheimer¡¯s Disease Drug Revenue and Market Share (%) by Types (2012-2017)
4.3 Global Alzheimer¡¯s Disease Drug Price (USD/Unit) by Type (2012-2017)
4.4 Global Alzheimer¡¯s Disease Drug Sales Growth by Type (2012-2017)
5 Global Alzheimer¡¯s Disease Drug Market Analysis by Applications
5.1 Global Alzheimer¡¯s Disease Drug Sales (M Units) and Market Share (%) by Applications (2012-2017)
5.2 Global Alzheimer¡¯s Disease Drug Sales Growth Rate (%) by Applications (2012-2017)
6 Analysis of Alzheimer¡¯s Disease Drug Industry Key Manufacturers
6.1 Allergan
6.1.1 Company Profile
6.1.2 Product Information
6.1.3 Sales, Price, Cost, Gross, and Revenue
6.2 Eisai
6.2.1 Company Profile
6.2.2 Product Information
6.2.3 Sales, Price, Cost, Gross, and Revenue
6.3 Novartis
6.3.1 Company Profile
6.3.2 Product Information
6.3.3 Sales, Price, Cost, Gross, and Revenue
6.4 Daiichi Sankyo
6.4.1 Company Profile
6.4.2 Product Information
6.4.3 Sales, Price, Cost, Gross, and Revenue
6.5 Merz Pharma
6.5.1 Company Profile
6.5.2 Product Information
6.5.3 Sales, Price, Cost, Gross, and Revenue
6.6 Pfizer
6.6.1 Company Profile
6.6.2 Product Information
6.6.3 Sales, Price, Cost, Gross, and Revenue
6.7 Johnson & Johnson
6.7.1 Company Profile
6.7.2 Product Information
6.7.3 Sales, Price, Cost, Gross, and Revenue
6.8 Lundbeck
6.8.1 Company Profile
6.8.2 Product Information
6.8.3 Sales, Price, Cost, Gross, and Revenue
7 Alzheimer¡¯s Disease Drug Manufacturing Cost Analysis
7.1 Alzheimer¡¯s Disease Drug R&D Cost Analysis
7.1.1Clinical Phase Costs
7.1.2 Capitalized Costs
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Alzheimer¡¯s Disease Drug
8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Alzheimer¡¯s Disease Drug Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.4 Downstream Buyers
9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.2 Market Positioning
9.2.1 Market Positioning
9.2.2 Brand Strategy
9.2.2.1 Introducing pharmaceutical branding strategies
9.2.2.2 Building pharmaceutical brands
9.2.2.3 Communicating pharmaceutical brands
9.2.2.4 Alternative brand models
9.2.2.5 The future of pharmaceutical branding
9.3 Distributors/Traders List
10 Alzheimer¡¯s drug-development pipeline
10.1 Phase III
10.2 Phase II
10.3 Phase I
10.4 Biomarkers
11 Global Alzheimer¡¯s Disease Drug Market Forecast (2017-2022)
11.1 Global Alzheimer¡¯s Disease Drug Sales (M Units), Revenue (M USD) Forecast (2017-2022)
11.1.1 Global Alzheimer¡¯s Disease Drug Sales (M Units) and Growth Rate (%) Forecast (2017-2022)
11.1.2 Global Alzheimer¡¯s Disease Drug Revenue (M USD) and Growth Rate (%) Forecast (2017-2022)
11.1.3 Global Alzheimer¡¯s Disease Drug Price and Trend Forecast (2017-2022)
11.2 Global Alzheimer¡¯s Disease Drug Sales (M Units) and Revenue (M USD) Forecast by Regions (2017-2022)
11.2.1 North America Alzheimer¡¯s Disease Drug Sales (M Units) and Revenue (M USD) Forecast (2017-2022)
11.2.2 Europe Alzheimer¡¯s Disease Drug Sales (M Units) and Revenue (M USD) Forecast (2017-2022)
11.2.3 China Alzheimer¡¯s Disease Drug Sales (M Units) and Revenue (M USD) Forecast (2017-2022)
11.2.4 Japan Alzheimer¡¯s Disease Drug Sales (M Units) and Revenue (M USD) Forecast (2017-2022)
11.3 Global Alzheimer¡¯s Disease Drug Sales (M Units), Revenue (M USD), Price (USD/Unit) Forecast by Type (2017-2022)
11.4 Global Alzheimer¡¯s Disease Drug Sales (M Units) Forecast by Application (2017-2022)
12 Research Findings and Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
List of Tables and Figures
Figure Product Picture of Alzheimer¡¯s Disease Drug
Table Alzheimer¡¯s Disease Drug Segment by Types
Figure Global Alzheimer¡¯s Disease Drug Sales Market Share (%) by Types in 2016
Figure Product Picture of Donepezil
Figure Product Picture of Memantine
Figure Product Picture of Rivastigmine
Table Global Alzheimer¡¯s Disease Drug Segment by Applications
Table Treatments at a Glance
Figure North America Alzheimer¡¯s Disease Drug Revenue (M USD) and Growth Rate (%) (2012-2022)
Figure China Alzheimer¡¯s Disease Drug Revenue (M USD) and Growth Rate (%) (2012-2022)
Figure Europe Alzheimer¡¯s Disease Drug Revenue (M USD) and Growth Rate (%) (2012-2022)
Figure Japan Alzheimer¡¯s Disease Drug Revenue (M USD) and Growth Rate (%) (2012-2022)
Figure Global Alzheimer¡¯s Disease Drug Revenue (M USD) Status and Outlook (2012-2022)
Figure Global Alzheimer¡¯s Disease Drug Sales (M Units) Status and Outlook (2012-2022)
Figure Global Alzheimer¡¯s Disease Drug Sales Market Share (%) by Applications in 2016
Table Global Alzheimer¡¯s Disease Drug Sales (M Units) of Key Manufacturers (2012-2017)
Figure 2016 Alzheimer¡¯s Disease Drug Sales Share (%) by Manufacturers
Figure 2017 Alzheimer¡¯s Disease Drug Sales Share (%) by Manufacturers
Table Global Alzheimer¡¯s Disease Drug Revenue (M USD) by Manufacturers (2012-2017)
Table 2016 Global Alzheimer¡¯s Disease Drug Revenue Share (%) by Manufacturers
Table 2017 Global Alzheimer¡¯s Disease Drug Revenue Share (%) by Manufacturers
Table Global Market Alzheimer¡¯s Disease Drug Average Price (USD/Unit) of Key Manufacturers (2012-2017)
Figure Global Market Alzheimer¡¯s Disease Drug Average Price (USD/Unit) of Key Manufacturers in 2016
Table Manufacturers Alzheimer¡¯s Disease Drug Headquarters and Found Date
Table Manufacturers Alzheimer¡¯s Disease Drug Brand
Table 2016 Global Alzheimer¡¯s Disease Drug Revenue Share (%) by Manufacturers
Figure Alzheimer¡¯s Disease Drug Market Share (%) of Top 3 Manufacturers
Figure Alzheimer¡¯s Disease Drug Market Share (%) of Top 5 Manufacturers
Table Mergers & Acquisitions, Expansion
Table Global Alzheimer¡¯s Disease Drug Sales (M Units) by Regions (2012-2017)
Table Global Alzheimer¡¯s Disease Drug Sales Market Share by Regions (2012-2017)
Figure 2016 Global Alzheimer¡¯s Disease Drug Sales Market Share (%) by Regions
Figure 2017 Global Alzheimer¡¯s Disease Drug Sales Market Share (%) by Regions
Table Global Alzheimer¡¯s Disease Drug Revenue (M USD) by Regions (2012-2017)
Table Global Alzheimer¡¯s Disease Drug Revenue Market Share (%) by Regions (2012-2017)
Figure 2016 Global Alzheimer¡¯s Disease Drug Revenue Market Share (%) by Regions
Figure 2017 Global Alzheimer¡¯s Disease Drug Revenue Market Share (%) by Regions
Table Global Alzheimer¡¯s Disease Drug Sales (M Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
Table North America Alzheimer¡¯s Disease Drug Sales (M Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
Table Europe Alzheimer¡¯s Disease Drug Sales (M Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
Table China Alzheimer¡¯s Disease Drug Sales (M Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
Table Japan Alzheimer¡¯s Disease Drug Sales (M Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
Table Global Alzheimer¡¯s Disease Drug Sales (M Units) by Types (2012-2017)
Table Global Alzheimer¡¯s Disease Drug Sales Share (%) by Types (2012-2017)
Figure 2016 Sales Market Share (%) of Alzheimer¡¯s Disease Drug by Types
Figure 2017 Sales Market Share (%) of Alzheimer¡¯s Disease Drug by Types
Table Global Alzheimer¡¯s Disease Drug Revenue (M USD) by Types (2012-2017)
Table Global Alzheimer¡¯s Disease Drug Revenue Share (%) by Types (2012-2017)
Figure 2016 Revenue Market Share (%) of Alzheimer¡¯s Disease Drug by Types
Figure 2017 Revenue Market Share (%) of Alzheimer¡¯s Disease Drug by Types
Table Global Alzheimer¡¯s Disease Drug Price (USD/Unit) by Types (2012-2017)
Figure Global Alzheimer¡¯s Disease Drug Sales Growth (%) by Type (2012-2017)
Table Global Alzheimer¡¯s Disease Drug Sales (M Units) by Applications (2012-2017)
Table Global Alzheimer¡¯s Disease Drug Sales Market Share (%) by Applications (2012-2017)
Figure Global Alzheimer¡¯s Disease Drug Sales Market Share (%) by Applications in 2016
Figure Global Alzheimer¡¯s Disease Drug Sales Market Share (%) by Applications in 2017
Figure Global Alzheimer¡¯s Disease Drug Sales Growth Rate (%) by Applications (2012-2017)
Table Allergan Company Profile
Table Alzheimer¡¯s Disease Drug Product Introduction of Allergan
Table Alzheimer¡¯s Disease Drug Ssles (M Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Allergan 2012-2017
Table Eisai Company Profile
Table Alzheimer¡¯s Disease Drug Product Introduction of Eisai
Table Alzheimer¡¯s Disease Drug Production (M Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Eisai 2012-2017
Table Novartis Company Profile
Table Alzheimer¡¯s Disease Drug Product Introduction of Novartis
Table Alzheimer¡¯s Disease Drug Production (M Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Novartis 2012-2017
Table Daiichi Sankyo Company Profile
Table Alzheimer¡¯s Disease Drug Product Introduction of Daiichi Sankyo
Table Alzheimer¡¯s Disease Drug Production (M Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Daiichi Sankyo 2012-2017
Table Merz Pharma Company Profile
Table Alzheimer¡¯s Disease Drug Product Introduction of Merz Pharma
Table Alzheimer¡¯s Disease Drug Production (M Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Merz Pharma 2012-2017
Table Pfizer Company Profile
Table Alzheimer¡¯s Disease Drug Product Introduction of Pfizer
Table Alzheimer¡¯s Disease Drug Production (M Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Pfizer 2012-2017
Table Johnson & Johnson Company Profile
Table Alzheimer¡¯s Disease Drug Product Introduction of Johnson & Johnson
Table Alzheimer¡¯s Disease Drug Production (M Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Johnson & Johnson 2012-2017
Table Lundbeck Company Profile
Table Alzheimer¡¯s Disease Drug Product Introduction of Lundbeck
Table Alzheimer¡¯s Disease Drug Production (M Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Lundbeck 2012-2017
Figure typical phases from research to the market for a drug candidate
Table Out-of-pocket Preclinical and Clinical Period Cost per Investigational Biopharmaceutical Compound
Table Capitalized Preclinical and Clinical Period costs per Investigational Biopharmaceutical Compound
Figure Manufacturing Cost Structure of Alzheimer¡¯s Disease Drug
Figure Assessment of API Manufacturing Cost By Region
Figure 2016 Manufacturing Labor Cost Per Hour in China as a Proportion of Those in Other Countries (%)
Figure Manufacturing Labor Costs in Select Provinces and Countries in 2016
Figure 2016 Global Manufacturing Competitiveness Index rankings by country
Figure US Nonfarm Unit Labor Cost 2014-2016
Figure United States Average Hourly Wages (USD/H) 2016-2017
Figure China Labor Cost Index 2014-2016
Figure China Average Yearly Wages 2006-2016
Figure Euro Area Labor Cost 2014-2016
Figure Japan Overview of Average Monthly Wages 2012-2017(JPY Thousand/Month)
Figure Manufacturing Process Analysis of Alzheimer¡¯s Disease Drug
Figure Alzheimer¡¯s Disease Drug Industrial Chain Analysis
Table Major Buyers of Alzheimer¡¯s Disease Drug
Figure Marketing Channel for Alzheimer¡¯s Disease
Figure Alzheimer¡¯s Disease Marketing Channel
Table Distributors/Traders List
Figure Agents currently in clinical trials for AD
Table Agents currently in phase III of development and their mechanism of action
Table Agents currently in phase II of AD drug development and their mechanism of action
Table Agents currently in phase I of development and their mechanism of action
Table Percent of trials with specific biomarkers included
Figure Global Alzheimer¡¯s Disease Drug Sales (M Units) and Growth Rate (%) Forecast (2017-2022)
Figure Global Alzheimer¡¯s Disease Drug Revenue (M USD) and Growth Rate (%) Forecast (2017-2022)
Figure Global Alzheimer¡¯s Disease Drug Price and Trend Forecast (2017-2022)
Table Global Alzheimer¡¯s Disease Drug Sales (M Units) Forecast by Regions (2017-2022)
Figure North America Alzheimer¡¯s Disease Drug Sales (M Units) and Growth Rate (%) Forecast (2017-2022)
Figure North America Alzheimer¡¯s Disease Drug Revenue and Growth Rate (%) Forecast (2017-2022)
Figure Europe Alzheimer¡¯s Disease Drug Sales (M Units) and Growth Rate (%) Forecast (2017-2022)
Figure Europe Alzheimer¡¯s Disease Drug Revenue and Growth Rate (%) Forecast (2017-2022)
Figure China Alzheimer¡¯s Disease Drug Sales (M Units) and Growth Rate (%) Forecast (2017-2022)
Figure China Alzheimer¡¯s Disease Drug Revenue and Growth Rate (%) Forecast (2017-2022)
Figure Japan Alzheimer¡¯s Disease Drug Sales (M Units) and Growth Rate (%) Forecast (2017-2022)
Figure Japan Alzheimer¡¯s Disease Drug Revenue and Growth Rate (%) Forec

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report